Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms
about
Candida albicans Biofilms and Human DiseaseMechanisms of Candida biofilm drug resistanceAntifungal lock therapySynergistic combinations of antifungals and anti-virulence agents to fight against Candida albicansThe Candida albicans Biofilm Matrix: Composition, Structure and FunctionNovel entries in a fungal biofilm matrix encyclopediaLarge-scale biochemical profiling of the Candida albicans biofilm matrix: new compositional, structural, and functional insights.Fungal biofilms, drug resistance, and recurrent infectionLife after death: the critical role of extracellular DNA in microbial biofilms.Saccharomyces cerevisiae biofilm tolerance towards systemic antifungals depends on growth phaseExtracellular DNA release confers heterogeneity in Candida albicans biofilm formation.Extrinsic extracellular DNA leads to biofilm formation and colocalizes with matrix polysaccharides in the human pathogenic fungus Aspergillus fumigatus.High-throughput nano-biofilm microarray for antifungal drug discoveryIn vitro analyses of mild heat stress in combination with antifungal agents against Aspergillus fumigatus biofilm.Fungal biofilm resistance.Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm DrugsFungal Super Glue: The Biofilm Matrix and Its Composition, Assembly, and Functions.Evaluation of Mannosidase and Trypsin Enzymes Effects on Biofilm Production of Pseudomonas aeruginosa Isolated from Burn Wound Infections.A common mechanism involving the TORC1 pathway can lead to amphotericin B-persistence in biofilm and planktonic Saccharomyces cerevisiae populations.Biofilm Exopolysaccharides of Pathogenic Fungi: Lessons from Bacteria.Antifungal therapy with an emphasis on biofilmsCandidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs.Biofilm-associated infections: antibiotic resistance and novel therapeutic strategies.Recent insights into Candida albicans biofilm resistance mechanismsFuture directions for anti-biofilm therapeutics targeting Candida.Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?Combinatorial drug approaches to tackle Candida albicans biofilms.Future therapies targeted towards eliminating Candida biofilms and associated infections.Fungal Biofilms: Update on Resistance.Fungal biofilm composition and opportunities in drug discovery.The Extracellular Matrix of Fungal Biofilms.Fungal Biofilms: Inside Out.Extracellular DNA release acts as an antifungal resistance mechanism in mature Aspergillus fumigatus biofilms.A snapshot of extracellular DNA influence on Aspergillus biofilm.Microbial glycoside hydrolases as antibiofilm agents with cross-kingdom activity.Microbial Biofilms in Pulmonary and Critical Care Diseases.Candida albicans Biofilm Development and Its Genetic Control.New Derivatives of Pyridoxine Exhibit High Antibacterial Activity against Biofilm-Embedded Staphylococcus Cells.Inactivation of genes TEC1 and EFG1 in Candida albicans influences extracellular matrix composition and biofilm morphologyInnovative strategies to overcome biofilm resistance.
P2860
Q26778729-1B156687-6199-44EC-8609-F765EC5BEAB7Q26827521-68D76714-CBD2-4C7E-9280-DAD0B7A45ADFQ27025682-758AEF54-F741-4E97-9FBE-F1F4271E3838Q28082407-4495DFAF-D149-4F7E-84A9-820BE6496710Q33684840-0A905022-1E24-41AB-B134-DB800CF5E106Q34026267-5E121F11-51EC-4E93-8572-D83FCC8EF303Q34237946-02D8FDA3-F302-4D25-9394-DF72909A4C7CQ34355341-2B368EB2-30F6-466A-8014-62AD57CD1855Q34357136-05FA91A5-2CE1-4E63-8DC0-BAE16F233892Q34643153-AB5BFD0C-124C-47AC-8BF5-2B72B1E1837DQ34676573-91C150C2-93C4-418E-B232-ACE85832B90BQ34768972-E0F19A03-FBD9-43A6-8A62-E929FBC4D6ABQ34783867-75D276B8-5486-4756-A90D-4B034F838BFFQ35068517-70301572-A014-4388-BFE0-63E87DF1EF8DQ35821475-A51B11F6-05AE-45DF-9E7C-67DAE4BA30DFQ36089061-50F76B10-6B63-4A04-BCB8-1055A5864546Q36148245-C3466713-EC5B-4377-A133-F35C97A1AFDEQ36162790-51B4CD6B-CD20-414E-A34A-FEA7B7B86258Q36605876-5F111EFC-95C0-4840-BCE1-C7CA795BF32AQ37066547-658DC597-BE21-44D4-A18F-F4169DBB712DQ37227837-8D751D47-094A-4629-B693-429F3201A31FQ37699331-87FD75C0-E473-4F12-AE94-73FE3D846A9AQ38120559-3D98B1A4-7502-46C1-9F96-98CF94437B20Q38131290-97293616-92A6-48D9-80DB-A9AC17C9C5ACQ38186068-7DCCDB5F-B001-43F2-8670-E8D5B630CB86Q38236893-6CED47AD-DC5A-4900-A053-A7F10AA8FAD3Q38526460-5AA764BF-4450-41FA-9B21-F3B196582862Q38786061-5EB83EDE-558F-4E03-88EB-4742081EC9EAQ38817837-68CE1396-3C39-4844-9EEF-4EA3BB1530C2Q38835071-DF6FC6E7-3B19-4DFA-A73A-2B87806695DFQ38856993-C1D5D414-714C-46E2-90C0-E9DC62757160Q39226110-96A61539-18FA-4ADC-B512-D0CE0BE7B601Q39932219-02E37722-DE12-446E-8F7C-9F39838949DAQ40071713-4E5B099E-D52A-4472-B33B-3062A35B8872Q40164444-A234FD0E-5818-4B74-9265-3B358B272899Q40635408-69ACC0F2-680E-4E02-B170-5E2A62A85618Q41103472-7347DAF0-A380-4A6A-AD2B-92D5D724CBC9Q42679246-DBE5B001-C835-4628-AD8B-FE0F746D577FQ42681379-CBC3964F-2C1E-4593-BD9D-C564BCBF0EAFQ43233956-01AC6F5B-ED44-4E05-B710-024616ACD704
P2860
Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Addition of DNase improves the ...... inst Candida albicans biofilms
@ast
Addition of DNase improves the ...... inst Candida albicans biofilms
@en
type
label
Addition of DNase improves the ...... inst Candida albicans biofilms
@ast
Addition of DNase improves the ...... inst Candida albicans biofilms
@en
prefLabel
Addition of DNase improves the ...... inst Candida albicans biofilms
@ast
Addition of DNase improves the ...... inst Candida albicans biofilms
@en
P2093
P2860
P1433
P1476
Addition of DNase improves the ...... inst Candida albicans biofilms
@en
P2093
José L Lopez-Ribot
Margarida Martins
Mariana Henriques
Rosário Oliveira
P2860
P356
10.1111/J.1439-0507.2011.02047.X
P577
2011-06-12T00:00:00Z